Pregnancy and SARS-CoV-2 Infection in Germany—the CRONOS Registry
; ; ; ;
When the COVID-19 pandemic took off in March 2020, the available data from China remained insufficient to estimate the risk of SARS-CoV-2 infection for pregnant women and neonates (1, 2). To be able to counsel and treat pregnant women on the basis of data generated in Germany, the research network of the German Society of Perinatal Medicine (DGPM) initiated the COVID-19 Related Obstetric and Neonatal Outcome Study (CRONOS). Information on the study is available at www.dgpm-online.org und from the German Clinical Trials Register (DRKS00021208). On the background of case numbers of infections rising once again, we present the initial results of the registry, which has been in existence since 3 April 2020.
All German maternity hospitals were invited to participate in the CRONOS registry. Obstetricians and neonatologists from 121 German hospitals and from Kepler University Hospital Linz, Austria, accepted this invitation. Ethics approval was obtained (University Hospital Schleswig-Holstein (UKSH) in Kiel, file number D 451/20). A reporting form was developed using the cloud-based electronic data capture platform of the service provider castoredc.com (Amsterdam, Netherlands). Women with confirmed SARS-CoV-2 infection during pregnancy were included. In addition to COVID-19 specific symptoms and treatments, pregnancy and birth specific events and neonatal outcomes were documented. The data were entered by each treating hospital. After patients had given informed consent, the further course of the pregnancy, the postpartum period, and the neonatal period were observed up to six week post partum. The data presented here were retrieved up to 1 October 2020. We used the software package Prism 8.3.0 (GraphPad Software, San Diego, USA) for our statistical analysis.
98 of the 122 hospitals participated actively in the registry. These hospitals provided care during the preceding year for 185 787 patients, and thus >20% of births in Germany. Between 3 April 2020 and 1 October 2020, 247 cases were registered by 65 hospitals. The affected pregnant women were mostly (71%) younger than 35 and mostly (79%) had a body mass index (BMI) <30 kg/m2. 38% of women were going through their first pregnancy. An underlying medical condition requiring long term medical treatment was documented in 11.8% of pregnant women. Important parameters of mother and child regarding SARS-CoV-2 infection and outcomes are shown in the Table. 14 (5.6%) women were treated in intensive care for COVID-19. Most of these patients did not have any particular risk factors. Five patients were either obese, presented with hypertension, or had a combination of these risk factors. 10 of the 14 women were infected during their third trimester. In 9 out of 14 cases, the SARS-CoV-2 infection affected the decision to affected the decision to deliver or the mode of delivery. 205 women have since recovered from SARS-CoV-2 infection. 185 have given birth. Four neonates (2.2%) tested positive for SARS-CoV-2 by polymerase chain reaction (PCR) on their first or second day of life; all were discharged into their home environment. A follow-up survey after the neonatal period in 56 families did not yield any case of neonatal infection.
The CRONOS registry data imply a mostly favorable course of SARS-CoV-2 infection in those pregnant women in Germany who were included in the study. The high rate of asymptomatic patients in the CRONOS registry can be explained by the introduction of comprehensive screening in hospitals (3) and is reflected in the positive outcomes. That said, in the group under study, rates of premature births and cesarean deliveries seemed slightly higher than the German average in previous years—but lower than is reflected in international data (4). Although intrauterine transmission of the virus with neuronal involvement of the neonate has been reported recently (5), such an event seems very rare.
A limitation of this study is the fact that no conclusions can be drawn on the actual prevalence in pregnant women in Germany because of the cohort study design. Similarly, owing to the currently low case numbers, no final conclusions can be drawn regarding risk factors for severe maternal courses and neonatal infections. However, known risk factors such as diabetes, hypertension, and obesity should prompt special attention, especially in infections occurring during the third trimester. The CRONOS data provide important information for counseling and caring for pregnant women and their newborns. Further hospitals have been invited to participate, with the aim of documenting all SARS-CoV-2 positive pregnant women in the population of Germany.
Ulrich Pecks, Lars Mense, Bettina Kuschel, Peter Oppelt, Mario Rüdiger on behalf of the CRONOS network: Alexander Hein, Angela Lihs, Anja Leonhardt, Anke Reitter, Ann Carolin Longardt, Antonella Iannaccone, Asimina Kartsiouni, Babett Ramsauer, Barbara Filsinger, Bastian Riebe, Carla Maier, Carsten Hagenbeck, Carsten Lehment, Cathleen Heinemann, Charlotte Rohlwink, Christian Schindlbeck, Christine Morfeld, Christoph Scholz, Claudia Lässer, Claudia Roll, Constantin von Kaisenberg, Corinna Keil, Cosmin Paul Sarac, Dietmar Schlembach, Edith Reuschel, Elisa Mendez Martorell, Elsa Hollatz Galuschki, Franz Edler von Koch, Georgi Popivanov, Gunnar Schwennicke, Hendrik Veldink, Ines Erhardt, Ioannis Kyvernitakis, Iris Dressler-Steinbach, Irmgard Drost, Jacqueline Lammert, Janine Zöllkau, Jeannette Teeuwen-Mutter, Johannes Stubert, Katharina Weizsäcker, Katrina Kraft, Kerstin Regner, Kerstin Spranger, Lars Hellmeyer, Lisa Kaup, Loredana Delle Chiaie, Maike Manz, Marek Struck, Maria Delius, Markus Schmidt, Martin Berghäuser, Michael Abou-Dakn, Michael K. Bohlmann, Mirjam Kunze, Monika Palz-Fleige, Nadine Mand, Nadja Hirschfeld, Nina Axnick, Norman Doehring, Olaf Parchmann, Parnian Parvanta, Peter Jakubowski, Ralf Schild, Rolf F. Maier, Sabine Enengl, Sarah Fill Malfertheiner, Sebastian Häusler, Silvia Lobmaier, Sönke Ebert, Sven Seeger, Tamina Rawnaq, Tamme Goecke, Tanja Groten, Tanja Ruebelmann, Thomas Kolben, Ulrich Henning, Ute Schäfer-Graf, Uwe Herwig, Vanessa Hepp, Verena Bossung, Vincent Winkler, Zoltan Takacs, and others.
Ulrich Pecks, Bettina Kuschel, Lars Mense, Peter Oppelt, Mario Rüdiger, CRONOS-Netzwerk
Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik für Gynäkologie und Geburtshilfe, Kiel (Pecks), Ulrich.Pecks@uksh.de
Klinikum Rechts der Isar Technische Universität München, Sektion Geburtshilfe und Perinatologie, München (Kuschel)
Medizinische Fakultät der Technischen Universität Dresden, Klinik für Kinder- und Jugendmedizin, Fachbereich Neonatologie und Pädiatrische Intensivmedizin, Dresden (Mense, Rüdiger)
Kepler Universitätsklinikum Linz, Universitätsklinik für Gynäkologie, Geburtshilfe & gyn. Endokrinologie, Linz, Österreich (Oppelt)
Zentrum für feto/neonatale Gesundheit an der Technischen Universität Dresden (Mense, Rüdiger)
Conflict of interest statement
Prof. Oppelt is in receipt of research support relating to COVID-19 (Corona Grant, Johannes-Keppler-University, Linz, Austria).
The remaining authors declare that no conflict of interest exists according to the guidelines of the International Committee of Medical Journal Editors.
Manuscript received on 10 August 2020, revised version accepted on 12 October 2020.
Translated from the original German by Birte Twisselmann, PhD.
Cite this asPecks U, Kuschel B, Mense L, Oppelt P, Rüdiger M, on behalf of the CRONOS network: Pregnancy and SARS-CoV-2 infection in Germany—the CRONOS registry. Dtsch Arztebl Int 2020; 117: 841–2. DOI: 10.3238/arztebl.2020.0841
|1.||Longardt AC, Winkler VP, Pecks U: SARS-CoV-2 and perinatal aspects. Z Geburtshilfe Neonatol 2020; 224: 181–6 CrossRef MEDLINE PubMed Central|
|2.||Zöllkau J, Hagenbeck C, Hecher K, et al.: Aktualisierte Empfehlungen zu SARS-CoV-2/COVID-19 und Schwangerschaft, Geburt und Wochenbett. Z Geburtshilfe Neonatol 2020; 224: 217–22 CrossRef MEDLINE PubMed Central|
|3.||Zöllkau J, Baier M, Scherag A, Schleußner E, Groten T: Period prevalence of SARS-CoV-2 in an unselected sample of pregnant women in Jena, Thuringia. Z Geburtshilfe Neonatol 2020; 224: 194–8 CrossRef MEDLINE PubMed Central|
|4.||Knight M, Bunch K, Vousden N, et al.: Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107 CrossRef MEDLINE PubMed Central|
|5.||Vivanti AJ, Vauloup-Fellous C, Prevot S, et al.: Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020; 11: 3572 CrossRef MEDLINE PubMed Central|
Antibody Response and Maternofetal Antibody Transfer in SARS-CoV-2-Positive Pregnant Women: A Multicenter Observational StudyGeburtshilfe und Frauenheilkunde, 202210.1055/a-1768-0415
Pregnant and Postpartum Women Requiring Intensive Care Treatment for COVID-19—First Data from the CRONOS-RegistryJournal of Clinical Medicine, 202210.3390/jcm11030701
Assessment of Neonatal Cord Blood SARS-CoV-2 Antibodies after COVID-19 Vaccination in Pregnancy: A Prospective Cohort StudyGeburtshilfe und Frauenheilkunde, 202210.1055/a-1721-4908
Postpartale Analyse des Nabelschnurbluts zum Ausschluss einer intrauterinen Transmission von SARS-CoV-2 bei positiven SchwangerenKongressabstracts zur Gemeinsamen Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) und der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde e.V. (BGGF)10.1055/s-0041-1730486
Der Anaesthesist, 202110.1007/s00101-021-01068-6